doi:10.3969/j.issn.1004-583X.2016.04.026

Abstract

CLC Number:

R541.6

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2016.04.026

https://huicui.hebmu.edu.cn/EN/Y2016/V31/I4/451

[1] Cavusoglu E, Chopra V,Gupta A, et al. Usefulness of anemia in men as all independent predictor of two-year cardiovascular outcome in patients presenting with acute coronary syndrome[J]. Am J Cardiol, 2006, 98(5): 580-584.
[2] Vaglio J, Safley DM, Rahman M,et al. Relation of anemia at discharge to survival after acute coronary syndromes[J]. Am J Cardiol,2005,96(4): 496-499.
[3] Aronson D, Suleiman M, Agmon Y, et al. Changes in haemoglobin levels during hospital course and long-term outcome after acute myocardial infarction[J].Eur Heart J, 2007, 28(11): 1289-1296.
[4] Kurek T, Lenarczyk R, Kowalczyk J, et al. Effect of anemia in high-risk groups of patients with acute myocardial infarction treated with percutaneous coronary intervention[J]. Am J Cardiol,2010,105(5): 611-618.
[5] Feng QZ,Zhao YS,Li YF.Effect of haemoglobin concentration on the clinical outcome in patients with acute myocardial infarction and the factors related to haemoglobin[J].BMC Res Notes,2011,4:142.
[6] Wang CH, Fang Q, Zhang SY, et al. Long-term effects of drug-eluting stents versus bare metal stents on patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcomes of 3-year clinical follow-up[J].Chin Med J(Engl), 2012,125(16):2803-2806.
[7] Jankowska EA, Rozentryt P,Witkowska A,et al.Iron deficiency: an ominous sign in patients with systolic chronicheart failure[J]. Eur Heart J, 2010,31(5):1872-1880.
[8] 郭俊. 红细胞生成素治疗慢性心力衰竭的临床观察[J].内科急危重症杂志,2011,17(5):308-309.
[9] 张消克,王杰萍,赵燕,等. 慢性心力衰竭合并贫血患者43例临床分析及预后[J].中国老年学杂志,2010,30(18):2666-2667.
[10] Anand IS, Kuskowski MA, Rector TS,et al. Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure[J]. Circulation,2005, 112(8):1121-1127.
[11] Palazzuoli A, Silverberg D, Iovine F,et al. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia[J]. Am Heart J, 2006,152(6): 1096.e92-1096.e15.
[12] Tarantini L, Oliva F,Cantoni Set,et al.Prevalence and prognostic role of anaemia in patients with acute heart failure and preserved or depressed ventricular function[J]. Intern Emerg Med, 2013, 8(2): 147-155.
[13] Kotecha D, Ngo K, Walters JA,et al.Erythropoietin as a treatment of anemia in heart failure: systematic review of randomized trials[J]. Am Heart J, 2011,161(5): 822-831.
[14] Portillo K, Martinez-Rivera C,Ruiz-Manzano J. Anaemia in chronic obstructive pulmonary disease. Does itreally matter?[J]. Int J Clin Pract,2013,67(6):558-565.
[15] Boutou AK, Stanopoulos I, Pitsiou GG, et al. Anemia of chronic disease in chronic obstructive pulmonary disease:a case-control study of eardiopulmonary exercise responses[J]. Respiration, 2011, 82(3): 237-245.
[16] Boutou AK, Karrar S, Hopkinson NS, et al. Anemia and survival in chronic obstructive pulmonary disease: a dichotomous rather than a continuous predictor[J]. Respiration, 2013,85(2):126-131.
[17] Krishnan G, Grant BJ, Muti PC, et al. Association between anemia and quality of life in a population sample of individuals with chronic obstructive pulmonary disease[J]. BMC Pulm Med, 2006, 6: 23.
[18] Cui H,Wei ZM, Fan L,et al. Clinical predictive value of hemoglobin level in mortality of hospitalized COPD patients[J]. Zhongguo Ying Yong Sheng Li Xue Za Zhi,2012,28(5):394-397.
[19] Chambellan A,Chailleux E,Similowski T,et al. Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy[J].Chest,2005,128(3):1201-1208.
[20] Cote C,Zilberberg MD, Mody SH, et al. Haemoglobin level and its clinical impact in a cohort of patients with COPD[J]. Eur Respir J, 2007,29(5): 923-929.
[21] Martinez-Rivera C, Portillo K,Mufioz-Ferrer A, et al. Anemia is a mortality predictor in hospitalized patients for COPD exacerbation[J]. COPD, 2012,9(3): 243-250.
[22] Yohannes AM,Ershler WB. Anemia in COPD:a systematic review of the prevalence,quality of life,and mortality[J].Respir Care,2011,56(5):644-652.
[23] Donzé J, Labarère J, Méan M,et al. Prognostic. importance of anaemia in patients with acute pulmonary embolism[J]. Thromb Haemost, 2011,106(2):289-295.
[24] Jiménez D, Escobar C, Martí D, et al.Association of anaemia and mortality in patients with acute pulmonary embolism[J].Thromb Haemost,2009,102(1):153-158.
[25] Silverberg DS, Wexler D,Iaina A,et al.Anaemia management in cardio renal disease[J].J Ren Care,2010,36(Suppl 1):86-96.
[26] Iaina A, Silverberg DS, Wexler D. Therapy insight congestive failure, chronic kidney disease and anemia, the cardio-renal-anemia syndrome [J]. Nat Clin Pract Cardiovasc Med, 2005,2(2):95-100.
[27] Hao Z, Wu B, Wang D, et al. A cohort study of patients with anemia on admission and fatality after acute ischemic stroke[J]. J Clin Neurosci, 2013, 20(1):37-42.
[28] Mustanoja S, Putaala J, Haapaniemi E, et al. Multiple brain infarcts in young adults:clues for etiologic diagnosis and prognostic impact[J]. Eur J Neurol, 2013, 20(2):216-222.
[29] Lee JH, Kim YJ, Moon Y, et al. Acute simultaneous multiple lacunar infarcts:a severe disease entity in small artery disease[J]. Eur Neurol, 2012, 67(5):303-311.
[30] Kimberly WT,Wu O,Arsava EM,et al. Lower hemoglobin correlates with larger stroke volumes in acute ischemic stroke[J]. Cerebrovasc Dis Extra, 2011,1(1):44-53.
[31] Hao Z,Wu B,Wang D,et al. A cohort study of patients with anemia on admission and fatality after acute ischemic stroke[J]. J Clin Neurosci,2013,20(1):37-42.
[32] Sico JJ,Concato J,Wells CK,et al. Anemia is associated with poor outcomes in patients with less severe ischemic stroke[J]. J Stroke Cerebrovasc Dis,2011,22(3):271-278.
[33] Lin LC,Lee TH,Chang CH,et al. Predictors of clinical deterioration during hospitalization following acute ischemic stroke[J]. Eur Neurol,2012,67(3):186-192.
[34] Kellert L,Martin E, Sykora M,et al. Cerebral oxygen transport failure.Decreasing hemoglobin and hematocrit levels after ischemic stroke predict poor outcome and mortality: STroke; RelevAnt Impact of hemoGlobin,Hematocrit and Transfusion (STRAIGHT)- an observational study[J]. Stroke,2011,42(10):2832-2837.
[35] Daffertshofer M, Mielke O,Pullwitt A,et al. Transient ischemic attacks are more than “ministrokes”[J]. Stroke,2004,35(11):2453-2458.
[36] Holgersson G,Sandelin M,Hoye E,et al. Swedish lung cancer radiation study group: the prognostic value of anaemia, thrombocytosis and leukocytosis attime of diagnosis in patients with non-small cell lung cancer[J]. Med Oncol,2012,29(5):3176-3182.
[37] Finkelmeier F, Bettinger D,Koberle V,et al.Single measurement of hemoglobin predicts outcome of HCC patients[J].Med Oncol,2014,31(1):806.
[38] 吴付兵,王明元,王康霞,等. 肿瘤相关性贫血的研究进展[J].现代肿瘤医学,2011,19(4): 825-828.
[39] 魏玮, 高勇, 王理伟,等. 细胞免疫状况与肿瘤相关性贫血患者生活质量的关系[J].肿瘤,2010, 30(5):406-409.
[40] 阮润生, 徐克成. 肿瘤免疫治疗的新策略[J].中华肿瘤杂志,2011,33(12): 943-946.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	. [J]. Clinical Focus, 2024, 39(1): 75-79.
[2]	Duan Fang, Cui Wei. Application principles of vasodilators in the treatment of acute heart failure [J]. Clinical Focus, 2023, 38(9): 773-778.
[3]	. [J]. Clinical Focus, 2023, 38(9): 832-837.
[4]	. [J]. Clinical Focus, 2023, 38(6): 573-576.
[5]	. [J]. Clinical Focus, 2023, 38(5): 459-464.
[6]	Wang Zhen, Yang Xiaoyue, Li Shaojie, Wang Xian, Chen Shuxia, Gu Jian. Analysis of clinical characteristics and readmission risk factors in patients with ejection fraction preserved heart failure combined with atrial fibrillation [J]. Clinical Focus, 2023, 38(4): 308-314.
[7]	. [J]. Clinical Focus, 2023, 38(4): 369-372.
[8]	Zuo Xiuxiu, Hou Tianhua, Wang Hongxiang. Effect of subclinical hypothyroidism on prognosis of patients with chronic systolic heart failure: A meta-analysis [J]. Clinical Focus, 2022, 37(10): 905-911.
[9]	. [J]. Clinical Focus, 2022, 37(9): 838-841.
[10]	Li Heng, Li Yonghui, Sun Xiaoqiang, Wang Lin, He Feng. Efficacy and safety of anticoagulant therapy for patients with heart failure in sinus rhythm [J]. Clinical Focus, 2022, 37(5): 406-411.
[11]	Luo Fanglin, Guan Suying, Wu Guoxiang. Clinical effect of sacubitril-valsartan combined with activin on acute left heart failure [J]. Clinical Focus, 2021, 36(9): 782-785.
[12]	. [J]. Clinical Focus, 2021, 36(7): 641-645.
[13]	Zhao Meili, Xiao Liyuan, Liu Lin, Kang Chao, Zhang Qiuxiang. Correlation between NT-proBNP, hs-CRP, left atrium diameter and chronic heart failure concurrent with atrial fibrillation [J]. Clinical Focus, 2021, 36(5): 412-415.
[14]	Xu Dongrui, Zhao Qinhui, Liu Tongxiang. Clinical effect of sacubitril/valsartan for heart failure with mid-range ejection fraction in left ventricle [J]. Clinical Focus, 2021, 36(5): 416-420.
[15]	Bai Lian, Guo Peng, Luan Bo, Bai Hao, Jiang Shan. Correlation between serum free fatty acid and cardiac function in patients with acute heart failure [J]. Clinical Focus, 2021, 36(3): 208-211.